Pharmaceuticals

The State of Innovation 2017

This year’s report on The State of Innovation showcases some of the latest inventions from around the world and focuses on trends in the top 12 industries.  The Pharmaceuticals industry highlighted some key trends that show a resurgence growth.

  • 20% year-over-year growth in the number of inventions appearing in patents
  • 108,799 published patents in organics
  • Top Innovator – China’s Lanzhou Inst Husbandry & Pharm Sci CAAS
  • Six of the top 10 pharmaceutical innovators globally come from China
  • Merck and Roche top list of heterocyclics inventions (2012 – 2016)
  • Most influential scientific research institution in pharmaceuticals (2006–2016) – UK’s University of Dundee edges out MIT

An overview of Pharmaceuticals innovation by subsector.

 

The State of Innovation: Insights into the Pharmaceuticals industry

The State of Innovation: Insights into the Pharmaceuticals industry

Download insights into the Pharmaceuticals industry to see the latest on The State of Innovation

Download report

Methodology

To produce The State Of Innovation Report an analytical approach is used, based on proprietary data sources, to identify current trends and key players.  Scientific literature highlights early signals emerging from scientific discovery and patent information is used to identify which ideas are taken up.

The key products used in this process are Web of Science, Derwent World Patents Index, Derwent Innovation and Cortellis.

Blog: Super-drugging the superbugs

by Gez Cross

We have seen a healthy 20 percent growth in patents published in 2016. In addition to the top three indications cancer, inflammatory diseases and diabetes, there is a renewed focus on antibiotics. This should not be too surprising as we confront the impending threat of drug-resistant superbugs.

 

Read the full blog post at: The Super-drugging the superbugs